Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known cause), confirmed using a recognised set of diagnostic standards called the UK Parkinson's Disease Society Brain Bank Criteria.
- People who are able to understand and follow the study procedures.
- People who have been on a stable Parkinson's medication routine before the study begins.
Who may not be able to join:
- People with significant memory or thinking difficulties, identified by a score below 23 on a standard cognitive assessment called the Mini-Mental State Examination (MMSE).
- People whose general verbal and intellectual ability falls below a certain level, identified by a score below 40 on a vocabulary test from the Wechsler Adult Intelligence Scale, Third Edition (WAIS-III) (confirm with trial site).
- People with a clinically significant level of depression, identified by a score above 10 on a depression screening tool called the Geriatric Depression Scale (GDS-15).
- People currently taking a type of medication called cholinesterase inhibitors, which are sometimes used for memory or thinking problems.
- People with serious heart or cardiovascular conditions, including heart failure, ischemic heart disease (reduced blood flow to the heart), a cardiac pacemaker, or a condition where blood pressure drops significantly when standing up (orthostatic hypotension).
- People with uncontrolled diabetes.
- People who have had a stroke or a traumatic brain injury at any point in the past.
- People with a history of seizures or epilepsy.
- People who have, or have previously had, a deep brain stimulation (DBS) device implanted.
- People who have had major bone or joint surgery in the past that could affect how they move or walk.
- People who have any implanted electronic device, including a cardiac pacemaker, that may be incompatible with the study procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Miguel Angel Fernández del Olmo, PhD, Universidad Rey Juan Carlos
Phone: +34 666 66 81 05
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gait Speed at Preferred Speed; Step length at Preferred Speed; Cadence at Preferred Speed; Gait Speed at Maximal Speed; Step Length at Maximal Speed; Cadence at Maximal Speed; Timed Up and Go test performance; Choice stepping reaction time; Choice arm reaching reaction time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.